Extended-spectrum beta-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria
- PMID: 12734278
- PMCID: PMC154721
- DOI: 10.1128/JCM.41.5.2197-2200.2003
Extended-spectrum beta-lactamase enzymes in clinical isolates of Enterobacter species from Lagos, Nigeria
Abstract
Over a 9-month period, 8 of 40 nonduplicate isolates of Enterobacter spp. producing extended-spectrum beta-lactamase (ESBL) were detected for the first time from two hospitals in Lagos, Nigeria. Microbiologic and molecular analysis confirmed the presence of ESBL. Only four isolates transferred ESBL resistance as determined by the conjugation test, and pulsed-field gel electrophoresis showed genetically unrelated isolates.
References
-
- Arlet, G., M. Rouveau, and A. Philippon. 1997. Substitution of alanine for aspartate at position 179 in the SHV-6 extended-spectrum β-lactamase. FEMS Microbiol. Lett. 152:163-167. - PubMed
-
- Burwen, D. R., S. N. Banerjee, R. P. Gaynes, and the National Nosocomial Infections Surveillance System. 1994. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J. Infect. Dis. 170:1622-1625. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
